Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	147.53	88.71	76.21	110.89	108.01	184.43
Short-Term Investments	-	692.41	578.28	292.74	268.39	183.36
Cash & Short-Term Investments	147.53	781.12	654.48	403.63	376.4	367.79
Cash Growth	-86.56%	19.35%	62.15%	7.23%	2.34%	16.58%
Accounts Receivable	15.69	4.82	-	-	1.41	10.26
Other Current Assets	80.96	162.29	40.99	12.85	27.49	6.55
Total Current Assets	1,840	950.64	695.47	416.47	405.3	384.6
Net Property, Plant & Equipment	417.62	346.01	431.56	335.56	168.59	66.02
Other Intangible Assets	6.01	2.86	2.56	10.26	11.96	13.66
Long-Term Investments	-	-	-	-	105.87	245.6
Other Long-Term Assets	4.89	1.39	4.48	3.26	0.22	0.27
Total Assets	2,268	1,385	1,140	765.55	691.94	710.15
Accounts Payable	30.75	17.67	11.39	35.87	2.87	9.46
Accrued Expenses	96.95	117.31	85.01	57.73	59.11	23.77
Short-Term Debt	40	40	-	-	-	-
Current Portion of Leases	7.77	7.29	6.34	10.56	2.78	2.25
Unearned Revenue	108.54	2.4	-	0.87	74.1	111.06
Other Current Liabilities	11.21	10.81	0.43	0.44	-	-
Total Current Liabilities	295.22	195.49	103.17	105.46	138.85	146.54
Long-Term Debt	1,225	582.28	734.54	268.33	-	-
Long-Term Leases	100.11	104.11	111.03	104.61	78.8	23.3
Other Long-Term Liabilities	48.62	-	-	-	55.95	131.5
Total Long-Term Liabilities	1,374	686.39	845.57	372.93	134.75	154.79
Total Liabilities	1,669	881.88	948.74	478.39	273.6	301.33
Common Stock	0.24	0.23	0.22	0.2	0.2	0.2
Treasury Stock	-53.19	-53.19	-	-	-	-
Additional Paid-in Capital	2,395	2,139	1,806	1,300	1,219	1,053
Accumulated Other Comprehensive Income	0.74	4.44	2	-3.22	-0.14	-0.07
Retained Earnings	-1,729	-1,627	-1,626	-1,026	-820.76	-644.69
Total Common Shareholders' Equity	613.98	463.5	182.69	271.34	398.52	408.82
Minority Interest	-15.06	20.42	8.37	15.82	19.82	-
Shareholders' Equity	598.92	503.92	191.06	287.16	418.34	408.82
Total Liabilities & Equity	2,268	1,385	1,140	765.55	691.94	710.15
Total Debt	1,373	733.68	851.91	383.5	81.58	25.55
Net Cash (Debt)	-1,226	47.44	-197.43	20.13	294.82	342.24
Net Cash Growth	-	-	-	-93.17%	-13.86%	16.27%
Net Cash Per Share	-8.80	0.35	-1.65	0.19	2.80	3.30
Book Value	613.98	463.5	182.69	271.34	398.52	408.82
Book Value Per Share	4.41	3.47	1.53	2.54	3.78	3.94
Tangible Book Value	607.97	460.64	180.13	261.08	386.56	395.16
Tangible Book Value Per Share	4.36	3.44	1.50	2.45	3.67	3.81

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q